CAG
43
2
BBY
48
2
CNX
59
-4
CA
24
-3
AMAT
54
-3
CTAS
40
6
AAP
24
-3
APD
44
9
VIX
21
-8
AZO
43
3
AVY
53
6
BAX
48
4
CSCO
63
-4
CCL
68
8
EFX
54
5
AEE
48
-2
DE
46
3
AVGO
33
-7
ALL
57
9
AIZ
59
5
CAG
43
2
BBY
48
2
CNX
59
-4
CA
24
-3
AMAT
54
-3
CTAS
40
6
AAP
24
-3
APD
44
9
VIX
21
-8
AZO
43
3
AVY
53
6
BAX
48
4
CSCO
63
-4
CCL
68
8
EFX
54
5
AEE
48
-2
DE
46
3
AVGO
33
-7
ALL
57
9
AIZ
59
5
Financhill
Back

ProShares Short Russell2000 Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
19

RWM
ProShares Short Russell2000

Last Price:
$15.83
Seasonality Move:
-4.01%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$87.93
Seasonality Move:
10.35%
Sell
19
ProShares Short Russell2000 (RWM) is a Sell

Is ProShares Short Russell2000 a Buy, Sell or Hold?

  • The current ProShares Short Russell2000 [RWM] share price is $15.82. The Score for RWM is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • RWM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

RWM Stock Price Chart

What is ProShares Short Russell2000's stock price today?

  • The ProShares Short Russell2000 share price today is $15.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RWM is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $87.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

RWM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 32.84 Sell
Chaikin Money Flow: -20520820 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.24 - 17.24) Sell
Bollinger Bands (100): (16.41 - 17.87) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.53 Buy
Relative Strength Index (14 RSI): 71.11 Buy
Chaikin Money Flow: -592960 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.18 - 78.14) Buy
Bollinger Bands (100): (43.11 - 66.09) Buy

RWM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.22 Sell
20-day SMA: 16.73 Sell
50-day SMA: 16.64 Sell
200-day SMA: 18.61 Sell
8-day EMA: 16.2 Sell
20-day EMA: 16.48 Sell
50-day EMA: 16.32 Sell
200-day EMA: 10.4 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.75 Buy
20-day SMA: 70.43 Buy
50-day SMA: 63.87 Buy
200-day SMA: 45.05 Buy
8-day EMA: 80.77 Buy
20-day EMA: 72.92 Buy
50-day EMA: 64.9 Buy
200-day EMA: 50.57 Buy

ProShares Short Russell2000 Earnings Growth & RWM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.

ProShares Short Russell2000 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):